3/3
08:21 am
imdx
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]
Medium
Report
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission [Yahoo! Finance]
3/3
08:00 am
imdx
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Medium
Report
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
2/27
03:35 pm
imdx
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And GraftAssureDx Catalyst [Yahoo! Finance]
Low
Report
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And GraftAssureDx Catalyst [Yahoo! Finance]
2/17
02:48 pm
imdx
Oncocyte (NASDAQ:IMDX) had its price target raised by analysts at Lake Street Capital from $8.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Oncocyte (NASDAQ:IMDX) had its price target raised by analysts at Lake Street Capital from $8.00 to $12.00. They now have a "buy" rating on the stock.
2/11
08:00 am
imdx
iMDx Announces $26.0 Million Registered Direct Offering
Medium
Report
iMDx Announces $26.0 Million Registered Direct Offering
1/14
09:22 am
imdx
Insight ‘congratulated' STAR working group on organ health testing paper [Yahoo! Finance]
Medium
Report
Insight ‘congratulated' STAR working group on organ health testing paper [Yahoo! Finance]
1/13
09:00 am
imdx
IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring
Low
Report
IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring
1/7
07:12 pm
imdx
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation [Yahoo! Finance]
Low
Report
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation [Yahoo! Finance]
1/7
04:05 pm
imdx
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation
Neutral
Report
iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation
1/6
08:11 am
imdx
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch [Yahoo! Finance]
Low
Report
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch [Yahoo! Finance]
1/6
08:00 am
imdx
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch
Low
Report
iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch
1/5
07:19 am
imdx
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion [Yahoo! Finance]
Medium
Report
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion [Yahoo! Finance]
1/5
07:00 am
imdx
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
Medium
Report
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
12/28
04:01 pm
imdx
Insiders Rewarded With US$5.2m Addition To Investment As Insight Molecular Diagnostics Stock Hits US$183m [Yahoo! Finance]
Medium
Report
Insiders Rewarded With US$5.2m Addition To Investment As Insight Molecular Diagnostics Stock Hits US$183m [Yahoo! Finance]
12/17
04:35 pm
imdx
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
04:19 pm
imdx
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/5
04:22 pm
imdx
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Oncocyte (NASDAQ:IMDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.